Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thailand's GPO Head Says Fixing Low-Yield H1N1 Vaccine Problem

This article was originally published in PharmAsia News

Executive Summary

The head of Thailand's Government Pharmaceutical Organization said the company now has enough eggs to grow the H1N1 flu virus and make a vaccine against the disease. GPO Chairman Vichai Chokevivat said he expects to produce the amount of vaccine as originally intended. The first batch of eggs produced a low yield of the live attenuate virus the GPO had been relying on, but a new batch obtained from elsewhere is being counted on to produce a normal yield. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072582

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel